骨髓水肿综合征的研究进展  

Research Progress of Bone Marrow Edema Syndrome

作　　者：洪志楠 HONG Zhinan(The Third Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510378)

机构地区：[1]广州中医药大学第三附属医院,广东广州510378

出　　处：《智慧健康》2023年第35期13-16,共4页Smart Healthcare

基　　金：广州中医药大学第三附属医院科研创新基金资助项目《脂肪细胞因子与膝骨关节炎软骨退变程度的相关性及祛瘀法干预研究》(项目编号:Sy2020015);广东省中医骨伤研究院开放课题重点项目《股骨头坏死围塌陷期保髋保髋手术临床研究》(项目编号:GYH202101-01);广东省中医药局科研项目《基于微生物-代谢-转录组学探究猫眼草黄素介导肠道菌群对骨吸收活跃型骨质疏松症的作用机制》(项目编号:20221199)。

摘　　要：骨髓水肿综合征(bone marrow edema syndrome,BMES)是发病率较低的一种骨科疾病,病因尚不明确,以髋部最为常见,与股骨头坏死(osteonecrosis of the femoral head,ONFH)临床表现类似,因此常被误诊误治,二者可通过MRI相鉴别。BMES作为一种自限性疾病,骨髓水肿是可逆的,多采用非手术治疗,目标是减轻患者的疼痛,同时缩短临床病程,疾病预后良好。Bone marrow edema syndrome(BMES)is a kind of orthopedic disease with low incidence,etiology is not clear,most common in the hip,with Osteonecrosis of the Femoral Head(ONFH)is similar in clinical presentation,so it is often misdiagnosed and mistreated,the two can be identified by MRI.As a self-limiting disease,BMES is reversible and is usually treated non-surgically.The goal is to reduce the pain of patients and shorten the clinical course of the disease.The prognosis is good.

关 键 词：髋关节 骨髓水肿综合征 股骨头坏死 鉴别诊断 

分 类 号：R681[医药卫生—骨科学]